Health Care: Drugs

Clovis Oncology Inc (CLVS: NASDAQ)

$66.28 0.22 | 0.34%
06/19/13 - 10:26 AM ET
Company Cash Flow
Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -73.98M -55.57M
Operating Gains/Losses 1.16M -16.00K
Extraordinary Gains / Losses 0.00 0.00
(Increase) Decrease In Receivables 0.00 0.00
(Increase) Decrease in Inventories 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00
(Decrease) Increase In Payables -758.00K 1.66M
(Decrease) Increase In Other Current Liabilities -110.00K 1.84M
(Increase) Decrease In Other Working Capital 0.00 924.00K
Other Non-Cash Items 4.95M 8.32M
Net Cash From Continuing Operations -65.38M -39.83M
Net Cash From Discontinued Operations 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -65.38M -39.83M
Sale of Property, Plant & Equipment 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 2.00M 9.61M
Purchases of Property, Plant & Equipment -1.06M -446.00K
Acquisitions 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00
Other Cash from Investing Activities 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 942.00K 9.17M
Issuance of Debt 0.00 27.90M
Cash Used for Financing Activities
Issuance of Capital Stock 70.29M 130.44M
Repayment of Long-Term Debt 0.00 0.00
Repurchase of Capital Stock 0.00 0.00
Payment of Cash Dividends 0.00 0.00
Other Financing Charges, Net 0.00 0.00
Net Cash From Financing Activities 70.29M 158.35M
Effect of Exchange Rate Changes 12.00K 42.00K
Net Change in Cash & Cash Equivalents 5.86M 127.73M

Portfolios with CLVS

View All

Latest CLVS Headlines from TheStreet

More Financial News for CLVS

Press Releases for CLVS

See All Press Releases

Partner Headlines for CLVS

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter